| 266.045 2.035 (0.77%) | 11-11 15:52 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 312.47  |
1-year : | 364.97 |
| Resists | First : | 267.52 |
Second : | 312.47 |
| Pivot price | 246.12 |
|||
| Supports | First : | 245.69 |
Second : | 232.19 |
| MAs | MA(5) : | 259.39 |
MA(20) : | 244.67 |
| MA(100) : | 240.45 |
MA(250) : | 230.03 |
|
| MACD | MACD : | 4.7 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 95.2 |
D(3) : | 91.3 |
| RSI | RSI(14): 78.4 |
|||
| 52-week | High : | 267.52 | Low : | 200.97 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ STE ] has closed below upper band by 3.8%. Bollinger Bands are 175.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 264.98 - 265.76 | 265.76 - 266.64 |
| Low: | 254.75 - 255.71 | 255.71 - 256.77 |
| Close: | 262.3 - 263.76 | 263.76 - 265.4 |
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Tue, 11 Nov 2025
Generation Investment Management LLP Sells 183,828 Shares of STERIS plc $STE - MarketBeat
Tue, 11 Nov 2025
Davis R M Inc. Has $1.53 Million Position in STERIS plc $STE - MarketBeat
Tue, 11 Nov 2025
STERIS plc $STE Shares Sold by Aviva PLC - MarketBeat
Tue, 11 Nov 2025
Interpreting Steris (STE) International Revenue Trends - sharewise.com
Mon, 10 Nov 2025
Rathbones Group PLC Has $26.88 Million Stock Position in STERIS plc $STE - MarketBeat
Mon, 10 Nov 2025
STERIS plc $STE Shares Sold by FDx Advisors Inc. - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 98 (M) |
| Shares Float | 98 (M) |
| Held by Insiders | 0.3 (%) |
| Held by Institutions | 97.4 (%) |
| Shares Short | 956 (K) |
| Shares Short P.Month | 1,130 (K) |
| EPS | 6.55 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 70.69 |
| Profit Margin | 11.6 % |
| Operating Margin | 17.8 % |
| Return on Assets (ttm) | 6.2 % |
| Return on Equity (ttm) | 9.7 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | 25.07 |
| Sales Per Share | 56.55 |
| EBITDA (p.s.) | 15.22 |
| Qtrly Earnings Growth | 22.1 % |
| Operating Cash Flow | 1,260 (M) |
| Levered Free Cash Flow | 910 (M) |
| PE Ratio | 40.6 |
| PEG Ratio | 0 |
| Price to Book value | 3.76 |
| Price to Sales | 4.7 |
| Price to Cash Flow | 20.79 |
| Dividend | 0.62 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|